Correction to: Efficacy of initial temozolomide for high?risk low grade gliomas in a phase II AINO (Italian Association for Neuro?Oncology) study: a post?hoc analysis within molecular subgroups of WHO 2016.
Autori:
Rudà R, Pellerino A, Pace A, Carapella CM, Dealis C, Caroli M, Faedi M, Bello L, Migliore E, Marchese G, Bertero L, Cassoni P, Soffietti R.
Rivista:
J Neurooncol 2019; 145: 593. doi:10.1007/s11060-019-03331-8 (IF 3.129)